Increased periocular pigmentation with ocular hypotensive lipid use in African Americans - 26/08/11
, Robert D. Williams, MD b, Martin Wand, MD c, Sanjay Asrani, MD aaAbstract |
Purpose |
To report increased eyelid pigmentation as an adverse side effect associated with topical ocular hypotensive lipids in African Americans.
Design |
Interventional case series.
Methods |
Two African-American patients with open-angle glaucoma are described in whom increased eyelid pigmentation developed 1 month to 5 months after beginning treatment with either latanoprost or bimatoprost.
Results |
Latanoprost was discontinued in an African-American patient, and pigmentation gradually diminished by 3 months after cessation of latanoprost. Increased eyelid pigmentation and increased eyelash length were noted in another African-American patient after just 4 weeks on bimatoprost.
Conclusions |
An increase in eyelid pigmentation and eyelash growth is a possible complication of topical ocular hypotensive lipid therapy, even in African-American patients. The changes seems to present earlier after bimatoprost treatment then after latanoprost treatment. Cessation of these medications may lead to loss of induced pigmentation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 135 - N° 5
P. 713-715 - mai 2003 Retour au numéro
Article précédent
- Camera artifacts producing thefalse impression of growth ofchoroidal melanocytic lesions
- Robert N Johnson, H.Richard McDonald, Everett Ai, J.Michael Jumper
- A case of occult macular dystrophy accompanying normal-tension glaucoma
- Makoto Nakamura, Akiyasu Kanamori, Ryu Seya, Hidetaka Maeda, Akira Negi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?